Evidence map›Paper›PMID 36363925›Full record

ReviewMicromachines2022

Sedimentation Stability of Magnetorheological Fluids: The State of the Art and Challenging Issues.

Seung-Bok Choi

Abstract readReview
In one paragraph

Review in Micromachines, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Experimental study of centrifugal pumping of magnetorheological fluid.Journal of intelligent material systems and structures · 2025
    Article
  4. Article
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Seung-Bok ChoiDepartment of Mechanical Engineering, The State University of New York, Korea (SUNY Korea), 119 Songdo Moonhwa-Ro, Yeonsu-Gu, Incheon 21985, Korea.ORCID 0000-0001-6262-2815

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Among the many factors causing particle sedimentation, three principal ingredients are heavily involved: magnetic particles, a carrier liquid (base oil), and additives (surfactant). Therefore, many works have been carried out to improve the sedimentation stability of magnetorheological fluids (MRFs) by adopting the three methods. In the particle modification stage, the weight concentration, size distribution, particle shape, coated materials, and combinations of different sizes of the particles have been proposed, while for the modification of the carrier liquid, several works on the density increment, wettability control, and the use of natural oils, lubricant oil, grease, and ethyl- and butyl-acetate oils have been undertaken. Recently, in certain recipes to improve sedimentation stability, some additives such as aluminum stearate were used to increase the redispersibility of the aggregated particles. In addition, several works using more than two recipes modifying both the particles and base oils are being actively carried out to achieve higher sedimentation stability. This review article comprehensively introduces and discuses the recipes to improve sedimentation stability from the aspects of the three ingredients. A few conceptual methodologies to prevent the sedimentation occurring via a bottle's storage on the shelves of the application systems are also presented, since, to the author's knowledge, there has not been a report on this issue. These are challenging works to be explored and developed for successful application systems' MRFs.

Indexed as

additiveadditive recipecarrier liquidmagnetic particlemagnetorheological (MR) fluidparticle treatmentsedimentation stability

Identifiers

PMID36363925
PMCPMC9696840

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.